aXichem AB
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXIC-A.ST research report →
Companywww.axichem.com
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, an natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was incorporated in 2007 and is based in Malmö, Sweden.
- CEO
- Torsten Helsing
- IPO
- 2011
- Employees
- 7
- HQ
- Malmö, SE
Price Chart
Valuation
- Market Cap
- $89.92M
- P/E
- -5.10
- P/S
- 4.87
- P/B
- 1.70
- EV/EBITDA
- -7.33
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 15.16%
- Op Margin
- -94.29%
- Net Margin
- -95.60%
- ROE
- -29.85%
- ROIC
- -30.19%
Growth & Income
- Revenue
- $18.45M · 115.24%
- Net Income
- $-17,633,000 · 1.01%
- EPS
- $-0.30 · 23.08%
- Op Income
- $-16,931,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $4.10
- 52W Low
- $1.14
- 50D MA
- $1.43
- 200D MA
- $2.16
- Beta
- -0.71
- Avg Volume
- 49.48K
Get TickerSpark's AI analysis on AXIC-A.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AXIC-A.ST Coverage
We haven't published any research on AXIC-A.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AXIC-A.ST Report →